Search research articles
Contact Us
Filters
Showing results (21-30 of 38) with videos related to
Page
of 4
Sort By:
American Journal of Respiratory Cell and Molecular Biology
|
March 29, 2002
Tumor necrosis factor-alpha-induced secretion of RANTES and interleukin-6 from human airway smooth muscle cells: modulation by glucocorticoids and beta-agonists
Alaina J Ammit, Aili L Lazaar, Carla Irani, et al.
British Journal of Clinical Pharmacology
|
August 12, 2017
Epithelial desquamation observed in a phase I study of an oral cathepsin C inhibitor (GSK2793660)
Bruce E Miller, Ruth J Mayer, Navin Goyal, et al.
BMC Pharmacology & Toxicology
|
June 21, 2015
The pharmacokinetics and pharmacodynamics of danirixin (GSK1325756)--a selective CXCR2 antagonist --in healthy adult subjects
Bruce E Miller, Sunil Mistry, Kevin Smart, et al.
ERJ Open Research
|
December 2, 2020
CXCL-8-dependent and -independent neutrophil activation in COPD: experiences from a pilot study of the CXCR2 antagonist danirixin
Holly R Keir, Hollian Richardson, Christina Fillmore, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
February 8, 2014
The pharmacokinetics of conventional and bioenhanced tablet formulations of danirixin (GSK1325756) following oral administration in healthy, elderly, human volunteers
Bruce E Miller, Kevin Smart, Sunil Mistry, et al.
Journal of Clinical Medicine
|
August 12, 2022
Study to Explore the Association of the Renin-Angiotensin System and Right Ventricular Function in Mechanically Ventilated Patients
Armand Mekontso Dessap, Kate Hanrott, William M Powley, et al.
Chest
|
November 26, 2016
Mechanisms of Vascular Dysfunction in COPD and Effects of a Novel Soluble Epoxide Hydrolase Inhibitor in Smokers
Lucy Yang, Joseph Cheriyan, David D Gutterman, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 5, 2002
Mast cell chymase modifies cell-matrix interactions and inhibits mitogen-induced proliferation of human airway smooth muscle cells
Aili L Lazaar, Michael I Plotnick, Umberto Kucich, et al.
Pulmonary Therapy
|
June 30, 2021
Effects of Recombinant Human Angiotensin-Converting Enzyme 2 on Response to Acute Hypoxia and Exercise: A Randomised, Placebo-Controlled Study
David A Hall, Kate Hanrott, Philipp Badorrek, et al.
Pulmonary Pharmacology & Therapeutics
|
November 15, 2020
Investigating the effect of TRPV4 inhibition on pulmonary-vascular barrier permeability following segmental endotoxin challenge
Sarah Mole, Anya Harry, Andy Fowler, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 38) with videos related to
Sort By:
Page
of 4
American Journal of Respiratory Cell and Molecular Biology
|
March 29, 2002
Tumor necrosis factor-alpha-induced secretion of RANTES and interleukin-6 from human airway smooth muscle cells: modulation by glucocorticoids and beta-agonists
Alaina J Ammit, Aili L Lazaar, Carla Irani, et al.
British Journal of Clinical Pharmacology
|
August 12, 2017
Epithelial desquamation observed in a phase I study of an oral cathepsin C inhibitor (GSK2793660)
Bruce E Miller, Ruth J Mayer, Navin Goyal, et al.
BMC Pharmacology & Toxicology
|
June 21, 2015
The pharmacokinetics and pharmacodynamics of danirixin (GSK1325756)--a selective CXCR2 antagonist --in healthy adult subjects
Bruce E Miller, Sunil Mistry, Kevin Smart, et al.
ERJ Open Research
|
December 2, 2020
CXCL-8-dependent and -independent neutrophil activation in COPD: experiences from a pilot study of the CXCR2 antagonist danirixin
Holly R Keir, Hollian Richardson, Christina Fillmore, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
February 8, 2014
The pharmacokinetics of conventional and bioenhanced tablet formulations of danirixin (GSK1325756) following oral administration in healthy, elderly, human volunteers
Bruce E Miller, Kevin Smart, Sunil Mistry, et al.
Journal of Clinical Medicine
|
August 12, 2022
Study to Explore the Association of the Renin-Angiotensin System and Right Ventricular Function in Mechanically Ventilated Patients
Armand Mekontso Dessap, Kate Hanrott, William M Powley, et al.
Chest
|
November 26, 2016
Mechanisms of Vascular Dysfunction in COPD and Effects of a Novel Soluble Epoxide Hydrolase Inhibitor in Smokers
Lucy Yang, Joseph Cheriyan, David D Gutterman, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 5, 2002
Mast cell chymase modifies cell-matrix interactions and inhibits mitogen-induced proliferation of human airway smooth muscle cells
Aili L Lazaar, Michael I Plotnick, Umberto Kucich, et al.
Pulmonary Therapy
|
June 30, 2021
Effects of Recombinant Human Angiotensin-Converting Enzyme 2 on Response to Acute Hypoxia and Exercise: A Randomised, Placebo-Controlled Study
David A Hall, Kate Hanrott, Philipp Badorrek, et al.
Pulmonary Pharmacology & Therapeutics
|
November 15, 2020
Investigating the effect of TRPV4 inhibition on pulmonary-vascular barrier permeability following segmental endotoxin challenge
Sarah Mole, Anya Harry, Andy Fowler, et al.
Page
of 4